146 related articles for article (PubMed ID: 10968196)
1. The calcium channel blocker controversy.
Kaplan NM
Hypertens Res; 1996 Jun; 19(2):57-64. PubMed ID: 10968196
[TBL] [Abstract][Full Text] [Related]
2. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
Opie LH; Yusuf S; Kübler W
Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers: association with myocardial infarction, mortality, and cancer.
Cheng JW; Behar L
Clin Ther; 1997; 19(6):1255-68; discussion 1253-4. PubMed ID: 9444438
[TBL] [Abstract][Full Text] [Related]
4. The safety of calcium-channel blockers.
Massie BM
Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
Opie LH
Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
[TBL] [Abstract][Full Text] [Related]
6. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
[TBL] [Abstract][Full Text] [Related]
8. Controversies concerning calcium antagonists.
Lichtlen PR
Cardiovasc Drugs Ther; 1996 Sep; 10(4):409-12. PubMed ID: 8924053
[TBL] [Abstract][Full Text] [Related]
9. The calcium channel blocker controversy in perspective.
Zanchetti A
Cardiology; 1997; 88 Suppl 1():66-70; discussion 71-2. PubMed ID: 9118170
[TBL] [Abstract][Full Text] [Related]
10. Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.
Bettiol A; Lucenteforte E; Vannacci A; Lombardi N; Onder G; Agabiti N; Vitale C; Trifirò G; Corrao G; Roberto G; Mugelli A; Chinellato A;
Clin Drug Investig; 2017 Dec; 37(12):1165-1174. PubMed ID: 28975522
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers in the dock: innocent or guilty?
Mackay JA; Sever PS
J Hum Hypertens; 1996 May; 10(5):277-80. PubMed ID: 8817399
[TBL] [Abstract][Full Text] [Related]
13. What, if anything, is controversial about calcium antagonists?
Messerli FH
Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
[TBL] [Abstract][Full Text] [Related]
14. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
15. 1995: the year of the calcium antagonist controversy.
Cohen JD
Curr Opin Nephrol Hypertens; 1996 May; 5(3):214-8. PubMed ID: 8737855
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.
Opie LH; Schall R
J Am Coll Cardiol; 2002 Jan; 39(2):315-22. PubMed ID: 11788225
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study.
Michels KB; Rosner BA; Manson JE; Stampfer MJ; Walker AM; Willett WC; Hennekens CH
Circulation; 1998 Apr; 97(16):1540-8. PubMed ID: 9593558
[TBL] [Abstract][Full Text] [Related]
18. [Differential therapy with calcium antagonists].
Scholze JE
Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
[TBL] [Abstract][Full Text] [Related]
19. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
Alcocer L; Bendersky M; Acosta J; Urina-Triana M
Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
